Melatonin Glenmark

Melatonin, the active ingredient in Melatonin Glenmark, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate the sleep‑wake cycle and is used to treat insomnia, jet lag and circadian‑rhythm sleep disorders in adults.

GNH USA supplies Melatonin Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Glenmark acts on the melatonin receptor pathway to support normal sleep regulation. - Insomnia: helps initiate sleep and improve sleep continuity in adults with difficulty falling asleep. - Jet lag: assists in adjusting the internal clock after rapid east‑west travel, reducing sleep disruption. - Circadian rhythm sleep disorders: supports alignment of the sleep‑wake cycle in shift‑work or delayed‑sleep‑phase conditions.

Melatonin Glenmark may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or mild stomach discomfort - Vivid dreams or nightmares - Mild fatigue

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling) - Severe skin eruption (Stevens‑Johnson syndrome) - Mood changes including depression or suicidal thoughts - Worsening of sleep‑apnea symptoms - Hallucinations or confusion - Severe hypotension (very rare)

Before using Melatonin Glenmark, consider the following safety measures. - Assess underlying sleep disorder: confirm diagnosis and rule out other causes of insomnia. - Avoid operating machinery or driving after dosing until you know how it affects you. - Use caution in patients with depression or mood disorders; monitor for mood changes. - Not recommended for children unless specifically prescribed by a qualified clinician. - Concomitant use with other sedatives may increase drowsiness; adjust timing accordingly. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonin Glenmark can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Benzodiazepines: additive central nervous system depression may cause excessive sedation. - Opioid analgesics: combined use can increase risk of respiratory depression and profound drowsiness. - Antihistamines with sedating properties: may amplify sleepiness and impair alertness.

Moderate Interactions (Monitor Closely): - Warfarin or other anticoagulants: melatonin may enhance anticoagulant effect, requiring INR monitoring. - Oral contraceptives: may raise melatonin plasma levels, potentially increasing side‑effects. - Anticonvulsants (e.g., carbamazepine, phenytoin): may reduce melatonin efficacy by increasing its metabolism. - Caffeine‑containing products: may diminish melatonin’s sleep‑promoting effect.